Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fangyu Zhou

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
Medicine|January 7, 2026
Comparative analysis of adverse events associated with epirubicin and doxorubicin: An observational study based on FDA Adverse Event Reporting System (FAERS) following STROBE guidelinesMengjie Yang, Fangyu Zhou, Jiamin Ma, et al.
Clinical Lung Cancer|December 3, 2014
Ceritinib (LDK378): a potent alternative to crizotinib for ALK-rearranged non-small-cell lung cancerSen Li, Xiaolong Qi, Yufeng Huang, et al.
Medicine|April 3, 2026
Evaluation of adverse event profiles for leuprolide and goserelin: Insights from the FDA adverse event reporting system following STROBE guidelinesFangyu Zhou, Mengjie Yang, Wenzhong Ji, et al.
Clinical Transplantation|July 10, 2023
Circulating exosomes from brain death and cardiac death donors have distinct molecular and immunologic properties: A pilot studyRanjithkumar Ravichandran, Yoshihiro Itabashi, Fangyu Zhou, et al.
Journal of Thoracic Disease|August 3, 2019
Age at diagnosis is a heterogeneous factor for non-small cell lung cancer patientsTao Chen, Fangyu Zhou, Weili Jiang, et al.
Biomaterials Science|July 25, 2025
Engineered PD-L1 nanoregulators for enhanced tumor immunotherapyMuhammad Inam, Ke Ren, Bowen Shen, et al.
Frontiers in Pharmacology|August 21, 2025
Comparative efficacy of eight traditional Chinese medicines combined with statins in the treatment of hyperlipidemia: a Bayesian network meta-analysisLing Jiang, Wen Fan, Fangyu Zhou, et al.
International Journal of Biological Sciences|September 13, 2021
The Role of Respiratory Microbiota in Lung CancerDan Wang, Jingyi Cheng, Jia Zhang, et al.
Scientific Reports|January 17, 2024
Road networks and socio-demographic factors to explore COVID-19 infection during its different wavesShahadat Uddin, Arif Khan, Haohui Lu, et al.
Biotechnology Journal|February 28, 2019
High-Affinity Antibody Detection with a Bivalent Circularized Peptide Containing Antibody-Binding DomainsFangyu Zhou, Andrew Kroetsch, Vyncent P Nguyen, et al.
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Medicine|January 7, 2026
Comparative analysis of adverse events associated with epirubicin and doxorubicin: An observational study based on FDA Adverse Event Reporting System (FAERS) following STROBE guidelinesMengjie Yang, Fangyu Zhou, Jiamin Ma, et al.
Clinical Lung Cancer|December 3, 2014
Ceritinib (LDK378): a potent alternative to crizotinib for ALK-rearranged non-small-cell lung cancerSen Li, Xiaolong Qi, Yufeng Huang, et al.
Medicine|April 3, 2026
Evaluation of adverse event profiles for leuprolide and goserelin: Insights from the FDA adverse event reporting system following STROBE guidelinesFangyu Zhou, Mengjie Yang, Wenzhong Ji, et al.
Clinical Transplantation|July 10, 2023
Circulating exosomes from brain death and cardiac death donors have distinct molecular and immunologic properties: A pilot studyRanjithkumar Ravichandran, Yoshihiro Itabashi, Fangyu Zhou, et al.
Journal of Thoracic Disease|August 3, 2019
Age at diagnosis is a heterogeneous factor for non-small cell lung cancer patientsTao Chen, Fangyu Zhou, Weili Jiang, et al.
Biomaterials Science|July 25, 2025
Engineered PD-L1 nanoregulators for enhanced tumor immunotherapyMuhammad Inam, Ke Ren, Bowen Shen, et al.
Frontiers in Pharmacology|August 21, 2025
Comparative efficacy of eight traditional Chinese medicines combined with statins in the treatment of hyperlipidemia: a Bayesian network meta-analysisLing Jiang, Wen Fan, Fangyu Zhou, et al.
International Journal of Biological Sciences|September 13, 2021
The Role of Respiratory Microbiota in Lung CancerDan Wang, Jingyi Cheng, Jia Zhang, et al.
Scientific Reports|January 17, 2024
Road networks and socio-demographic factors to explore COVID-19 infection during its different wavesShahadat Uddin, Arif Khan, Haohui Lu, et al.
Biotechnology Journal|February 28, 2019
High-Affinity Antibody Detection with a Bivalent Circularized Peptide Containing Antibody-Binding DomainsFangyu Zhou, Andrew Kroetsch, Vyncent P Nguyen, et al.
Pageof 7